Epidemiologic studies are needed to clarify whether dental modalities could be predictors of bisphosphonate osteonecrosis of the jaw in breast cancer patients.
Kyrgidis
Athanassios
A
Andreadis
Charalambos
C
D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000473:pathology*; D004164:Diphosphonates / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology; D019647:Oral Surgical Procedures; D010020:Osteonecrosis / Q000453:epidemiology* / Q000209:etiology / Q000473:pathology
D050071:Bone Density Conservation Agents; D004164:Diphosphonates